REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 27th, 2021 • Quotient LTD • In vitro & in vivo diagnostic substances
This Agreement is being entered into pursuant to the Purchase Agreement, dated as of May 23, 2021, by and among the Company, the Guarantors party thereto (as defined therein), and the Buyers (as amended from time to time, the “Purchase Agreement”) in respect of the Company’s 4.75% Convertible Senior Notes due 2026 (the “Notes”), issued pursuant to the terms of the Indenture (as defined below).
QUOTIENT LIMITED, as the Issuer, THE GUARANTORS PARTY HERETO, AND WILMINGTON SAVINGS FUND SOCIETY, FSB, as Trustee INDENTURE Dated as of May 26, 2021 4.75% Convertible Senior Notes due 2026Quotient LTD • May 27th, 2021 • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of May 26, 2021, among QUOTIENT LIMITED, a registered public limited liability no par value company incorporated under the laws of Jersey, Channel Islands with registration number 109886, having its registered office at 28 Esplanade, St. Helier, JE2 3QA Jersey, Channel Islands, as issuer (the “Company”, as more fully set forth in Section 1.01), the Guarantors party hereto (as defined herein) and WILMINGTON SAVINGS FUND SOCIETY, FSB, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
PURCHASE AGREEMENT dated May 23, 2021 among QUOTIENT LIMITED, THE GUARANTORS NAMED HEREIN and THE PURCHASERS NAMED HEREIN $95,000,000 4.75% CONVERTIBLE SENIOR NOTES DUE 2026Purchase Agreement • May 27th, 2021 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of May 26, 2021, among QUOTIENT LIMITED, a registered public limited liability no par value company incorporated under the laws of Jersey, Channel Islands with registration number 109886, having its registered office at 28 Esplanade, St. Helier, JE2 3QA Jersey, Channel Islands, as issuer (the “Company”, as more fully set forth in Section 1.01), the Guarantors party hereto (as defined herein) and WILMINGTON SAVINGS FUND SOCIETY, FSB, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
THIRD SUPPLEMENTAL INDENTUREThird Supplemental Indenture • May 27th, 2021 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
This Third Supplemental Indenture (this “Supplemental Indenture”), is entered into as of May 24, 2021, among Quotient Limited, a public limited liability no par value company formed under the laws of Jersey, Channel Islands (the “Issuer”), the Guarantors party hereto, and U.S. Bank National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
